Unique ID issued by UMIN | UMIN000008648 |
---|---|
Receipt number | R000010122 |
Scientific Title | A New Eating-Behavior Modification Program (BOOCS) Improves Glycemic Control, Treatment Satisfaction and Emotional Distress in Patients With Mild Type 2 Diabetes – A Randomized Controlled Trial |
Date of disclosure of the study information | 2012/08/08 |
Last modified on | 2012/08/08 15:30:50 |
A New Eating-Behavior Modification Program (BOOCS) Improves Glycemic Control, Treatment Satisfaction and Emotional Distress in Patients With Mild Type 2 Diabetes – A Randomized Controlled Trial
BOOCS-program improves mild type 2 diabetes
A New Eating-Behavior Modification Program (BOOCS) Improves Glycemic Control, Treatment Satisfaction and Emotional Distress in Patients With Mild Type 2 Diabetes – A Randomized Controlled Trial
BOOCS-program improves mild type 2 diabetes
Japan |
type 2 Diabetes
Medicine in general | Endocrinology and Metabolism |
Others
NO
To evaluate the effects of a new eating-behavior modification program (BOOCS), on the glycemic control, treatment satisfaction and emotional distress of type 2 diabetes.
Efficacy
HbA1c, blood glucose, IRI,serum lipids, Body weight,DTSQ, PAID
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
2
Treatment
Behavior,custom |
Sixty three out-patients with type 2 diabetes followed by diet therapy only (average HbA1c: 7.6%, BMI: 25.4kg/m2) were randomly divided into the standard-therapy group and BOOCS-therapy group, and were observed for one year. The standard-therapy group took a low caloric and restricted diet.
BOOCS-therapy group followed a non-restricted diet which aims to take pleasantness and satisfaction.
30 | years-old | <= |
Not applicable |
Male and Female
(a) male or female, 30 years or older, (b) attending an education program on diabetes regarding the cause of the disease, process, complications, exercise therapy, and diet therapy by conventional calorie control, and visiting the hospital continuously for 6 months or more.
(a) not receiving pharmacologic treatment, such as an oral hypoglycemic agent or insulin, and treatment for 8 weeks prior to the start of the trial has only been diet therapy, and (b) without unstable diabetes complications, alcohol addiction, or mental illness.
63
1st name | |
Middle name | |
Last name | Takehiko Fujino |
BOOCS Medical Corporation
Director
6-18-6F, Tenyamachi, Hakata-ku, Fukuoka-shi Fukuoka 812-0025 Japan
1st name | |
Middle name | |
Last name |
BOOCS Medical Corporation
BOOCS Clinic Fukuoka
6-18-6F, Tenyamachi, Hakata-ku, Fukuoka-shi Fukuoka 812-0025 Japan
092-283-6852
fujino-t@boocsclinic.com
Fukuoka Seishukai Hospital
Fukuoka Seishukai Hospital
Self funding
NO
2012 | Year | 08 | Month | 08 | Day |
Unpublished
Completed
2001 | Year | 01 | Month | 26 | Day |
2001 | Year | 02 | Month | 01 | Day |
2002 | Year | 04 | Month | 30 | Day |
2012 | Year | 08 | Month | 08 | Day |
2012 | Year | 08 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010122